Exelon (EXC) Financials

$44.67 -0.27 (-0.60%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$45.16 +0.49 (+1.10%)

As of 08/1/2025 07:28 PM Eastern

Annual Income Statements for Exelon

This table shows Exelon's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	1,697	1,121	3,779	2,005	2,936	1,963	1,706	2,170	2,328	2,460
Consolidated Net Income / (Loss)	1,669	1,196	3,869	2,079	3,028	1,954	1,829	2,171	2,328	2,460
Net Income / (Loss) Continuing Operations	0.00	32,514	3,869	2,079	3,028	1,099	1,616	2,054	2,328	2,460
Total Pre-Tax Income	3,330	1,973	3,775	2,225	3,985	1,092	1,654	2,403	2,702	2,667
Total Operating Income	2,748	34,530	4,388	3,891	4,374	2,191	2,682	3,315	4,023	4,319
Total Gross Profit	2,730	40,090	9,498	19,308	10,326	6,301	7,006	8,032	8,927	9,405
Total Revenue	11,052	62,684	33,558	35,978	34,438	16,663	17,938	19,078	21,727	23,028
Operating Revenue	11,052	62,684	33,558	35,978	34,438	16,663	17,938	19,078	21,727	23,028
Total Cost of Revenue	8,322	22,594	24,060	16,670	24,112	10,362	10,932	11,046	12,800	13,623
Operating Cost of Revenue	8,322	22,594	24,060	16,670	24,112	10,362	10,932	11,046	12,800	13,623
Total Operating Expenses	-18	5,560	5,110	15,417	5,952	4,110	4,324	4,717	4,904	5,086
Depreciation Expense	-	3,936	3,828	4,353	4,252	2,891	3,033	3,325	3,506	3,594
Other Operating Expenses / (Income)	0.00	1,576	1,518	11,120	1,731	1,232	1,291	1,390	1,408	1,504
Other Special Charges / (Income)	-18	48	-236	-56	-31	-13	0.00	2.00	-10	-12
Total Other Income / (Expense), net	-1,079	-1,239	-613	-1,666	-389	-1,099	-1,028	-912	-1,321	-1,652
Interest Expense	-	1,536	1,560	1,554	1,616	1,307	1,289	1,447	1,729	1,914
Other Income / (Expense), net	-	297	947	-112	1,227	208	261	535	408	262
Income Tax Expense	-	753	-126	118	774	-7.00	38	349	374	207
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	855	213	117	0.00	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-28	75	90	74	92	-9.00	123	1.00	0.00	0.00
Weighted Average Basic Shares Outstanding	890M	924M	947M	967M	973M	976M	979M	986M	996M	1.00B
Weighted Average Diluted Shares Outstanding	893M	927M	949M	969M	974M	977M	980M	987M	997M	1.00B
Weighted Average Basic & Diluted Shares Outstanding	890M	924M	946.50M	966.30M	973M	2.56B	1.29B	1.30B	1.31B	1.31B
Cash Dividends to Common per Share	$1.24	$0.00	$1.31	$1.38	$1.45	$1.53	$1.53	$1.35	$1.44	$1.52

This table shows Exelon's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	676	-	669	343	700	616	658	448	707	647	908
Consolidated Net Income / (Loss)	676	-	669	343	700	616	658	448	707	647	-7.00
Net Income / (Loss) Continuing Operations	676	-	669	343	700	616	658	448	707	647	-7.00
Total Pre-Tax Income	768	-	803	416	767	716	721	494	757	695	-7.00
Total Operating Income	1,011	-	1,106	704	1,123	1,090	1,114	913	1,196	1,096	0.00
Total Gross Profit	2,213	-	3,472	3,091	3,583	-1,219	3,633	3,369	3,771	-1,368	0.00
Total Revenue	4,845	-	5,563	4,818	5,980	5,366	6,043	5,361	6,154	5,470	0.00
Total Cost of Revenue	2,632	-	2,091	1,727	2,397	6,585	2,410	1,992	2,383	6,838	0.00
Total Operating Expenses	1,202	-	2,366	2,387	2,460	-2,309	2,519	2,463	2,575	-2,471	0.00
Total Other Income / (Expense), net	-243	-	-303	-288	-356	-374	-393	-419	-439	-401	-7.00
Interest Expense	365	-	412	427	437	453	468	483	496	467	7.00
Basic Earnings per Share	-	-	$0.67	$0.34	$0.70	$0.62	$0.66	$0.45	$0.70	-	$0.90
Weighted Average Basic Shares Outstanding	988M	986M	995M	995M	996M	996M	1B	1.00B	1.00B	1.00B	1.01B
Diluted Earnings per Share	-	-	$0.67	$0.34	$0.70	$0.62	$0.66	$0.45	$0.70	-	$0.90
Weighted Average Diluted Shares Outstanding	989M	987M	996M	996M	997M	997M	1.00B	1.00B	1.00B	1.00B	1.01B
Weighted Average Basic & Diluted Shares Outstanding	1.30B	1.30B	1.30B	1.30B	1.30B	1.31B	1.31B	1.31B	1.31B	1.31B	1.32B
Cash Dividends to Common per Share	$0.34	$0.34	$0.36	$0.36	$0.36	$0.36	$0.38	$0.38	$0.38	-	$0.40

This table details how cash moves in and out of Exelon's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	4,624	-5,798	276	-3,841	-659	44	453	-529	11	-162
Net Cash From Operating Activities	7,616	8,461	7,480	4,303	6,659	4,235	3,012	4,870	4,703	5,569
Net Cash From Continuing Operating Activities	7,558	8,461	6,024	4,303	5,433	5,533	3,012	4,870	4,703	5,569
Net Income / (Loss) Continuing Operations	2,250	1,196	3,869	0.00	3,028	1,954	1,829	2,171	2,328	2,460
Consolidated Net Income / (Loss)	2,250	1,196	3,869	-	3,028	1,954	1,829	2,171	2,328	2,460
Depreciation Expense	3,987	5,576	5,427	5,971	5,780	6,527	7,573	3,533	3,506	3,596
Non-Cash Adjustments To Reconcile Net Income	1,643	2,138	-169	-1,217	1,027	553	-940	833	-4.00	708
Changes in Operating Assets and Liabilities, net	-322	-449	-1,647	-451	-3,176	-4,799	-5,450	-1,667	-1,127	-1,195
Net Cash From Investing Activities	-7,822	-15,450	-7,971	-7,925	-7,260	-4,336	-3,317	-6,990	-7,375	-7,042
Net Cash From Continuing Investing Activities	-7,822	-15,450	-7,971	-7,925	-7,260	-4,336	-3,317	-6,990	-7,375	-7,042
Purchase of Property, Plant & Equipment	-7,624	-8,553	-7,584	-7,594	-7,248	-8,048	-7,981	-7,147	-7,408	-7,097
Purchase of Investments	-7,147	-9,738	-8,113	-8,997	-10,087	-3,464	-6,673	-516	0.00	0.00
Sale of Property, Plant & Equipment	147	61	219	-	53	46	877	16	25	38
Sale and/or Maturity of Investments	6,895	9,496	7,845	8,762	10,051	3,341	6,532	488	0.00	0.00
Other Investing Activities, net	-53	207	-43	58	12	3,789	3,928	169	8.00	17
Net Cash From Financing Activities	4,830	1,191	767	-219	-58	145	758	1,591	2,683	1,311
Net Cash From Continuing Financing Activities	4,830	1,183	767	-219	-58	145	758	1,591	2,683	1,311
Repayment of Debt	-2,706	-2,836	-3,784	-1,895	-713	-6,415	-1,801	-2,689	-2,290	-2,215
Payment of Dividends	-1,105	-1,174	-1,236	-1,332	-1,408	-1,492	-2,382	-1,334	-1,433	-1,524
Issuance of Debt	6,709	4,956	4,091	2,903	1,951	8,007	4,861	7,609	6,225	4,859
Issuance of Common Equity	1,932	427	1,696	105	112	45	80	599	181	191
Other Financing Activities, net	0.00	0.00	-	0.00	0.00	0.00	0.00	-2,594	0.00	0.00

This table details how cash moves in and out of Exelon's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	701	-183	-7.00	-48	-88	154	207	227	-302	-294	643
Net Cash From Operating Activities	3,737	729	484	1,277	1,531	1,411	992	1,462	1,689	1,426	1,200
Net Cash From Continuing Operating Activities	3,737	729	484	1,277	1,531	1,411	992	1,462	1,689	1,426	1,200
Net Income / (Loss) Continuing Operations	1,739	432	669	343	699	617	658	448	707	647	908
Consolidated Net Income / (Loss)	-	432	669	343	699	617	658	448	707	647	908
Depreciation Expense	-	854	860	867	889	890	880	894	909	913	905
Non-Cash Adjustments To Reconcile Net Income	278	112	-25	-99	118	2.00	84	225	-20	419	467
Changes in Operating Assets and Liabilities, net	-959	-669	-1,020	166	-175	-98	-630	-105	93	-553	-1,080
Net Cash From Investing Activities	-5,312	-2,004	-1,871	-1,804	-1,840	-1,860	-1,767	-1,700	-1,647	-1,928	-1,942
Net Cash From Continuing Investing Activities	-5,312	-2,004	-1,871	-1,804	-1,840	-1,860	-1,767	-1,700	-1,647	-1,928	-1,942
Purchase of Property, Plant & Equipment	-	-1,968	-1,881	-1,804	-1,855	-1,868	-1,767	-1,699	-1,695	-1,936	-1,946
Sale of Property, Plant & Equipment	-	-	0.00	-	-	25	2.00	-	-	-	0.00
Other Investing Activities, net	-133	-36	10	-	15	-17	-2.00	1.00	10	8.00	4.00
Net Cash From Financing Activities	2,276	1,092	1,380	479	221	603	982	465	-344	208	1,385
Net Cash From Continuing Financing Activities	2,276	1,092	1,380	479	221	603	982	465	-344	208	1,385
Repayment of Debt	-3,098	759	-2,197	-846	467	286	-1,423	-766	221	-247	-810
Payment of Dividends	-	-335	-358	-359	-357	-359	-381	-380	-381	-382	-403
Issuance of Debt	5,801	658	3,925	1,675	100	525	2,775	1,600	-343	827	2,425
Issuance of Common Equity	572	10	10	9.00	11	151	11	11	159	10	173

This table presents Exelon's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	95,384	114,904	116,770	119,634	124,977	129,317	133,013	95,349	101,856	107,784
Total Current Assets	15,334	12,412	11,896	13,328	12,037	12,562	13,957	7,336	8,087	8,384
Cash & Equivalents	6,502	635	898	1,349	587	663	672	407	445	357
Restricted Cash	205	253	207	247	358	438	321	566	482	541
Accounts Receivable	912	5,359	5,577	5,863	6,223	4,700	2,865	3,561	3,361	3,754
Inventories, net	1,566	1,638	1,651	1,685	1,768	1,722	581	755	801	853
Prepaid Expenses	-	-	-	-	-	-	-	-	413	494
Current Deferred & Refundable Income Taxes	0.00	1,250	0.00	0.00	0.00	0.00	-	-	0.00	0.00
Other Current Assets	2,962	3,277	3,563	3,280	3,149	4,152	1,683	2,047	2,585	2,385
Plant, Property, & Equipment, net	57,439	71,555	74,202	76,707	80,233	82,584	64,558	69,076	73,593	78,182
Total Noncurrent Assets	22,405	30,937	30,672	29,599	32,707	34,171	54,498	18,937	20,176	21,218
Long-Term Investments	639	629	640	625	464	440	250	232	251	290
Noncurrent Note & Lease Receivables	0.00	-	0.00	0.00	0.00	0.00	0.00	2,897	3,232	4,026
Goodwill	2,672	6,677	6,677	6,677	6,677	6,677	6,630	6,630	6,630	6,630
Employee Benefit Assets	-	-	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00
Other Noncurrent Operating Assets	19,094	23,631	23,355	22,297	25,566	27,054	9,109	9,178	10,063	10,272
Total Liabilities & Shareholders' Equity	95,384	114,904	116,770	119,634	124,977	129,317	133,013	95,349	101,856	107,784
Total Liabilities	68,062	87,292	84,583	86,587	90,404	94,449	98,218	70,605	76,101	80,863
Total Current Liabilities	9,118	13,457	10,798	11,404	14,185	12,771	16,111	10,611	9,901	9,611
Short-Term Debt	2,033	3,697	3,017	2,063	6,080	3,850	3,401	4,388	3,926	3,312
Accounts Payable	3,193	3,441	3,889	3,805	3,565	3,567	2,384	3,387	2,851	2,999
Accrued Expenses	2,376	3,460	1,837	2,112	1,981	2,078	1,137	1,226	1,375	1,468
Customer Deposits	0.00	-	0.00	0.00	0.00	-	-	-	411	446
Other Current Liabilities	1,516	2,700	2,055	2,647	2,559	2,901	1,249	1,610	1,338	1,386
Total Noncurrent Liabilities	58,854	73,835	73,785	75,183	76,219	81,678	82,107	59,994	66,200	71,252
Long-Term Debt	23,645	31,575	32,176	34,075	31,329	35,093	30,749	35,662	40,082	43,337
Asset Retirement Reserve & Litigation Obligation	13,807	14,336	21,041	20,409	22,031	22,993	9,899	9,381	9,843	10,499
Noncurrent Deferred & Payable Income Tax Liabilities	13,776	18,138	11,235	11,321	12,351	13,035	10,611	11,250	11,956	12,793
Noncurrent Employee Benefit Liabilities	5,003	6,096	5,829	5,916	6,323	6,514	2,862	1,616	2,098	2,217
Other Noncurrent Operating Liabilities	1,982	3,049	3,504	3,462	4,185	4,043	2,310	2,085	2,221	2,406
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	27,294	27,612	32,187	33,047	34,573	34,868	34,795	24,744	25,755	26,921
Total Preferred & Common Equity	25,793	25,837	29,896	30,741	32,224	32,585	34,393	24,744	25,755	26,921
Total Common Equity	25,793	25,837	29,896	30,741	32,224	32,585	34,393	24,744	0.00	0.00
Common Stock	18,676	18,794	18,964	19,116	19,274	19,373	20,324	20,908	21,114	21,338
Retained Earnings	12,068	12,030	14,081	14,743	16,267	16,735	16,942	4,597	5,490	6,426
Treasury Stock	-2,327	-2,327	-123	-123	-123	-123	-123	-123	-123	-123
Accumulated Other Comprehensive Income / (Loss)	-2,624	-2,660	-3,026	-2,995	-3,194	-3,400	-2,750	-638	-726	-720

This table presents Exelon's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Total Assets	93,455	95,349	98,080	99,259	101,856	103,211	105,113	106,070	107,784	109,484
Total Current Assets	7,055	7,336	7,542	7,519	8,087	8,212	8,557	8,023	8,384	8,799
Cash & Equivalents	446	407	399	300	445	720	934	616	357	1,004
Restricted Cash	744	566	435	435	482	489	530	552	541	578
Accounts Receivable	3,430	3,561	3,125	3,314	3,361	3,585	3,709	3,660	3,754	4,016
Inventories, net	757	755	710	762	801	788	824	855	853	833
Prepaid Expenses	-	-	-	-	413	-	-	-	494	240
Current Deferred & Refundable Income Taxes	0.00	-	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1,678	2,047	2,968	2,708	2,585	2,630	2,560	2,340	2,385	2,128
Plant, Property, & Equipment, net	67,572	69,076	71,300	72,458	73,593	74,604	75,646	76,661	78,182	79,177
Total Noncurrent Assets	18,828	18,937	19,238	19,282	20,176	20,395	20,910	21,386	21,218	21,508
Long-Term Investments	230	232	238	246	251	263	270	279	290	289
Noncurrent Note & Lease Receivables	2,658	2,897	3,120	2,923	3,232	3,382	3,840	4,322	4,026	4,110
Goodwill	6,630	6,630	6,630	6,630	6,630	6,630	6,630	6,630	6,630	6,630
Employee Benefit Assets	-	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Other Noncurrent Operating Assets	9,310	9,178	9,250	9,483	10,063	10,120	10,170	10,155	10,272	10,479
Total Liabilities & Shareholders' Equity	93,455	95,349	98,080	99,259	101,856	103,211	105,113	106,070	107,784	109,484
Total Liabilities	68,873	70,605	73,001	73,789	76,101	77,150	78,961	79,448	80,863	81,877
Total Current Liabilities	8,717	10,611	7,936	8,800	9,901	7,975	8,275	7,384	9,611	8,103
Short-Term Debt	2,990	4,388	2,741	3,374	3,926	2,709	2,762	1,985	3,312	2,538
Accounts Payable	2,698	3,387	0.00	2,689	2,851	2,819	2,815	2,653	2,999	2,698
Accrued Expenses	1,213	1,226	1,220	1,315	1,375	1,076	1,241	1,284	1,468	1,186
Customer Deposits	-	-	-	-	411	419	425	432	446	465
Other Current Liabilities	1,816	1,610	1,464	1,422	1,338	952	1,032	1,030	1,386	1,216
Total Noncurrent Liabilities	60,156	59,994	65,454	64,989	66,200	69,175	70,686	72,064	71,252	73,774
Long-Term Debt	35,283	35,662	40,271	39,821	40,082	42,661	43,429	44,091	43,337	45,732
Asset Retirement Reserve & Litigation Obligation	9,110	9,381	9,679	9,505	9,843	9,976	10,470	10,852	10,499	10,594
Noncurrent Deferred & Payable Income Tax Liabilities	11,113	11,250	11,547	11,792	11,956	12,199	12,358	12,551	12,793	13,081
Noncurrent Employee Benefit Liabilities	2,162	1,616	1,571	1,600	2,098	2,092	2,086	2,081	2,217	1,955
Other Noncurrent Operating Liabilities	2,488	2,085	2,386	2,271	2,221	2,247	2,343	2,489	2,406	2,412
Total Equity & Noncontrolling Interests	24,582	24,744	25,079	25,470	25,755	26,061	26,152	26,622	26,921	27,607
Total Preferred & Common Equity	24,582	24,744	25,079	25,470	25,755	26,061	26,152	26,622	26,921	27,607
Total Common Equity	24,582	24,744	25,079	25,470	0.00	26,061	26,152	26,622	0.00	27,607
Common Stock	20,895	20,908	20,941	20,956	21,114	21,129	21,152	21,320	21,338	21,517
Retained Earnings	4,502	4,597	4,891	5,233	5,490	5,767	5,835	6,161	6,426	6,931
Treasury Stock	-123	-123	-123	-123	-123	-123	-123	-123	-123	-123
Accumulated Other Comprehensive Income / (Loss)	-692	-638	-630	-596	-726	-712	-712	-736	-720	-718
Other Equity Adjustments	-	-	-	0.00	-	0.00	0.00	0.00	-	0.00

This table displays calculated financial ratios and metrics derived from Exelon's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-92.15%	467.17%	-46.46%	7.21%	-4.28%	-51.61%	7.65%	6.36%	13.89%	5.99%
EBITDA Growth	-36.89%	499.90%	-73.36%	-9.40%	16.73%	-21.57%	17.81%	-29.79%	7.50%	3.02%
EBIT Growth	-59.61%	1,167.36%	-84.68%	-29.17%	48.21%	-57.17%	22.68%	30.82%	15.09%	3.39%
NOPAT Growth	-54.54%	676.98%	-78.76%	-18.74%	-4.35%	-37.44%	18.84%	8.13%	22.33%	14.93%
Net Income Growth	-69.38%	-28.34%	223.50%	-46.27%	45.65%	-35.47%	-6.40%	18.70%	7.23%	5.67%
EPS Growth	35.11%	-52.36%	228.93%	-47.99%	45.65%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	70.88%	11.10%	-11.59%	-42.47%	54.75%	-36.40%	-28.88%	61.69%	-3.43%	18.41%
Free Cash Flow Firm Growth	213.74%	-72.08%	-51.00%	132.79%	-108.52%	615.73%	1,672.01%	-129.90%	73.54%	112.21%
Invested Capital Growth	-10.51%	44.60%	5.58%	1.83%	5.59%	1.58%	-23.31%	15.67%	7.86%	5.54%
Revenue Q/Q Growth	-91.18%	87.60%	-16.78%	1.20%	-1.33%	-49.91%	24.49%	0.00%	0.00%	0.45%
EBITDA Q/Q Growth	-54.74%	43.58%	-37.84%	-10.73%	8.58%	3.98%	107.79%	82.39%	128.73%	0.20%
EBIT Q/Q Growth	-74.88%	50.94%	-54.58%	-24.16%	21.00%	-43.66%	116.40%	0.00%	0.00%	-0.15%
NOPAT Q/Q Growth	-64.12%	32.19%	-46.09%	-27.26%	2.13%	-29.52%	213.88%	0.00%	0.00%	2.22%
Net Income Q/Q Growth	105.32%	79.58%	78.21%	-46.92%	30.46%	-16.03%	-2.51%	0.00%	0.00%	1.28%
EPS Q/Q Growth	0.00%	0.00%	80.09%	-46.79%	30.46%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	49.04%	-9.07%	10.47%	-49.27%	5,992.92%	-0.45%	-64.66%	61.69%	16.96%	0.27%
Free Cash Flow Firm Q/Q Growth	-83.43%	105.51%	-82.05%	-4.76%	-125.52%	-12.54%	-74.47%	91.14%	75.52%	-43.47%
Invested Capital Q/Q Growth	617.49%	0.83%	2.36%	0.38%	1.98%	0.85%	1,544.02%	3.51%	1.33%	1.59%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	24.70%	63.96%	28.30%	53.67%	29.98%	37.81%	39.06%	42.10%	41.09%	40.84%
EBITDA Margin	60.94%	64.46%	32.07%	27.10%	33.05%	53.57%	58.62%	38.70%	36.53%	35.51%
Operating Margin	24.86%	55.09%	13.08%	10.81%	12.70%	13.15%	14.95%	17.38%	18.52%	18.76%
EBIT Margin	24.86%	55.56%	15.90%	10.50%	16.26%	14.40%	16.41%	20.18%	20.39%	19.89%
Profit (Net Income) Margin	15.10%	1.91%	11.53%	5.78%	8.79%	11.73%	10.20%	11.38%	10.71%	10.68%
Tax Burden Percent	50.12%	60.62%	102.49%	93.44%	75.98%	178.94%	110.58%	90.35%	86.16%	92.24%
Interest Burden Percent	121.18%	5.67%	70.76%	58.88%	71.15%	45.52%	56.20%	62.42%	60.98%	58.22%
Effective Tax Rate	0.00%	38.17%	-3.34%	5.30%	19.42%	-0.64%	2.30%	14.52%	13.84%	7.76%
Return on Invested Capital (ROIC)	6.04%	40.61%	7.10%	5.56%	5.13%	3.10%	4.14%	4.78%	5.24%	5.65%
ROIC Less NNEP Spread (ROIC-NNEP)	0.40%	-39.61%	5.14%	0.79%	3.71%	2.41%	1.36%	2.53%	2.46%	2.20%
Return on Net Nonoperating Assets (RNNOA)	0.29%	-36.25%	5.84%	0.81%	3.83%	2.53%	1.11%	2.51%	3.98%	3.69%
Return on Equity (ROE)	6.32%	4.36%	12.94%	6.37%	8.96%	5.63%	5.25%	7.29%	9.22%	9.34%
Cash Return on Invested Capital (CROIC)	17.13%	4.14%	1.67%	3.75%	-0.31%	1.53%	30.53%	-9.75%	-2.31%	0.27%
Operating Return on Assets (OROA)	3.30%	33.12%	4.61%	3.20%	4.58%	1.89%	2.24%	3.37%	4.49%	4.37%
Return on Assets (ROA)	2.00%	1.14%	3.34%	1.76%	2.48%	1.54%	1.39%	1.90%	2.36%	2.35%
Return on Common Equity (ROCE)	6.12%	4.10%	12.06%	5.92%	8.34%	5.25%	5.05%	7.24%	4.52%	0.00%
Return on Equity Simple (ROE_SIMPLE)	6.47%	4.63%	12.94%	6.76%	9.40%	6.00%	5.32%	8.77%	9.04%	9.14%
Net Operating Profit after Tax (NOPAT)	2,748	21,352	4,534	3,685	3,524	2,205	2,620	2,834	3,466	3,984
NOPAT Margin	24.86%	34.06%	13.51%	10.24%	10.23%	13.23%	14.61%	14.85%	15.95%	17.30%
Net Nonoperating Expense Percent (NNEP)	5.64%	80.22%	1.96%	4.78%	1.42%	0.69%	2.78%	2.25%	2.79%	3.45%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	4.37%	4.97%	5.42%
Cost of Revenue to Revenue	75.30%	36.04%	71.70%	46.33%	70.02%	62.19%	60.94%	57.90%	58.91%	59.16%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	-0.16%	8.87%	15.23%	42.85%	17.28%	24.67%	24.11%	24.72%	22.57%	22.09%
Earnings before Interest and Taxes (EBIT)	2,748	34,827	5,335	3,779	5,601	2,399	2,943	3,850	4,431	4,581
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	6,735	40,403	10,762	9,750	11,381	8,926	10,516	7,383	7,937	8,177
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.96	1.29	1.32	1.53	1.53	1.46	1.96	2.10	0.00	0.00
Price to Tangible Book Value (P/TBV)	1.08	1.74	1.70	1.95	1.93	1.83	2.42	2.87	0.00	0.00
Price to Revenue (P/Rev)	2.25	0.53	1.18	1.31	1.43	2.85	3.75	2.73	2.06	2.14
Price to Earnings (P/E)	14.66	29.75	10.47	23.45	16.77	24.17	39.44	23.99	19.27	20.06
Dividend Yield	6.07%	4.66%	4.20%	3.74%	3.77%	4.13%	2.92%	3.37%	4.18%	4.04%
Earnings Yield	6.82%	3.36%	9.55%	4.26%	5.96%	4.14%	2.54%	4.17%	5.19%	4.99%
Enterprise Value to Invested Capital (EV/IC)	1.04	1.11	1.15	1.25	1.24	1.22	1.83	1.43	1.28	1.31
Enterprise Value to Revenue (EV/Rev)	4.05	1.10	2.24	2.31	2.54	5.23	5.61	4.77	4.04	4.12
Enterprise Value to EBITDA (EV/EBITDA)	6.64	1.70	7.00	8.54	7.70	9.76	9.57	12.31	11.05	11.59
Enterprise Value to EBIT (EV/EBIT)	16.27	1.98	14.11	22.03	15.64	36.32	34.18	23.61	19.79	20.69
Enterprise Value to NOPAT (EV/NOPAT)	16.27	3.23	16.60	22.59	24.85	39.52	38.39	32.08	25.30	23.80
Enterprise Value to Operating Cash Flow (EV/OCF)	5.87	8.14	10.07	19.35	13.15	20.58	33.40	18.67	18.64	17.02
Enterprise Value to Free Cash Flow (EV/FCFF)	5.74	31.65	70.60	33.53	0.00	79.87	5.20	0.00	0.00	507.56
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.94	1.28	1.09	1.09	1.08	1.12	0.98	1.62	1.71	1.73
Long-Term Debt to Equity	0.87	1.14	1.00	1.03	0.91	1.01	0.88	1.44	1.56	1.61
Financial Leverage	0.72	0.92	1.14	1.03	1.03	1.05	0.82	0.99	1.62	1.68
Leverage Ratio	3.16	3.83	3.87	3.62	3.62	3.66	3.77	3.84	3.91	3.98
Compound Leverage Factor	3.83	0.22	2.74	2.13	2.57	1.67	2.12	2.39	2.38	2.32
Debt to Total Capital	48.47%	56.09%	52.23%	52.23%	51.97%	52.76%	49.53%	61.81%	63.08%	63.41%
Short-Term Debt to Total Capital	3.84%	5.88%	4.48%	2.98%	8.45%	5.22%	4.93%	6.77%	5.63%	4.50%
Long-Term Debt to Total Capital	44.64%	50.21%	47.75%	49.25%	43.52%	47.54%	44.60%	55.04%	57.45%	58.91%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.83%	2.82%	3.40%	3.33%	3.26%	3.09%	0.58%	0.00%	0.00%	0.00%
Common Equity to Total Capital	48.69%	41.09%	44.37%	44.43%	44.77%	44.15%	49.88%	38.19%	0.00%	0.00%
Debt to EBITDA	3.81	0.87	3.27	3.71	3.29	4.36	3.25	5.42	5.54	5.70
Net Debt to EBITDA	2.72	0.84	3.11	3.48	3.16	4.19	3.13	5.26	5.40	5.56
Long-Term Debt to EBITDA	3.51	0.78	2.99	3.49	2.75	3.93	2.92	4.83	5.05	5.30
Debt to NOPAT	9.34	1.65	7.76	9.81	10.61	17.66	13.03	14.13	12.70	11.71
Net Debt to NOPAT	6.67	1.58	7.38	9.21	10.21	16.96	12.56	13.71	12.36	11.41
Long-Term Debt to NOPAT	8.60	1.48	7.10	9.25	8.89	15.91	11.73	12.59	11.56	10.88
Altman Z-Score	0.69	1.91	0.90	0.92	0.91	0.67	0.78	0.80	0.76	0.79
Noncontrolling Interest Sharing Ratio	3.21%	5.97%	6.80%	7.05%	6.88%	6.67%	3.85%	0.68%	51.00%	100.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.68	0.92	1.10	1.17	0.85	0.98	0.87	0.69	0.82	0.87
Quick Ratio	0.81	0.45	0.60	0.63	0.48	0.41	0.22	0.37	0.38	0.43
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	7,795	2,177	1,066	2,483	-212	1,091	19,333	-5,781	-1,530	187
Operating Cash Flow to CapEx	101.86%	99.64%	101.56%	56.66%	92.55%	52.92%	42.40%	68.29%	63.70%	78.89%
Free Cash Flow to Firm to Interest Expense	0.00	1.42	0.68	1.60	-0.13	0.83	15.00	-4.00	-0.88	0.10
Operating Cash Flow to Interest Expense	0.00	5.51	4.79	2.77	4.12	3.24	2.34	3.37	2.72	2.91
Operating Cash Flow Less CapEx to Interest Expense	0.00	-0.02	0.07	-2.12	-0.33	-2.88	-3.17	-1.56	-1.55	-0.78
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.13	0.60	0.29	0.30	0.28	0.13	0.14	0.17	0.22	0.22
Accounts Receivable Turnover	0.00	19.99	6.14	6.29	5.70	3.05	4.74	5.94	6.28	6.47
Inventory Turnover	5.25	14.10	14.63	9.99	13.97	5.94	9.49	16.54	16.45	16.47
Fixed Asset Turnover	0.20	0.97	0.46	0.48	0.44	0.20	0.24	0.29	0.30	0.30
Accounts Payable Turnover	4.92	6.81	6.56	4.33	6.54	2.91	3.67	3.83	4.10	4.66
Days Sales Outstanding (DSO)	0.00	18.26	59.47	58.03	64.05	119.63	76.97	61.47	58.14	56.39
Days Inventory Outstanding (DIO)	69.50	25.88	24.95	36.52	26.14	61.47	38.45	22.07	22.19	22.16
Days Payable Outstanding (DPO)	74.23	53.59	55.60	84.23	55.78	125.61	99.35	95.35	88.94	78.37
Cash Conversion Cycle (CCC)	-4.74	-9.45	28.82	10.32	34.40	55.49	16.07	-11.80	-8.61	0.18
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	42,992	62,167	65,635	66,837	70,573	71,687	54,974	63,589	68,585	72,382
Invested Capital Turnover	0.24	1.19	0.53	0.54	0.50	0.23	0.28	0.32	0.33	0.33
Increase / (Decrease) in Invested Capital	-5,047	19,175	3,468	1,202	3,736	1,114	-16,713	8,615	4,996	3,797
Enterprise Value (EV)	44,709	68,879	75,289	83,250	87,581	87,140	100,590	90,910	87,684	94,803
Market Capitalization	24,876	33,349	39,550	47,027	49,232	47,455	67,281	52,065	44,854	49,342
Book Value per Share	$21.19	$21.02	$23.60	$24.15	$25.21	$25.42	$26.78	$19.04	$0.00	$0.00
Tangible Book Value per Share	$19.00	$15.59	$18.33	$18.90	$19.99	$20.22	$21.62	$13.94	($5.09)	($5.06)
Total Capital	52,972	62,884	67,380	69,185	71,982	73,811	68,945	64,794	69,763	73,570
Total Debt	25,678	35,272	35,193	36,138	37,409	38,943	34,150	40,050	44,008	46,649
Total Long-Term Debt	23,645	31,575	32,176	34,075	31,329	35,093	30,749	35,662	40,082	43,337
Net Debt	18,332	33,755	33,448	33,917	36,000	37,402	32,907	38,845	42,830	45,461
Capital Expenditures (CapEx)	7,477	8,492	7,365	7,594	7,195	8,002	7,104	7,131	7,383	7,059
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,542	1,764	3,010	2,391	2,987	2,540	254	140	1,185	1,187
Debt-free Net Working Capital (DFNWC)	8,249	2,652	4,115	3,987	3,932	3,641	1,247	1,113	2,112	2,085
Net Working Capital (NWC)	6,216	-1,045	1,098	1,924	-2,148	-209	-2,154	-3,275	-1,814	-1,227
Net Nonoperating Expense (NNE)	1,079	20,156	665	1,606	496	251	791	663	1,138	1,524
Net Nonoperating Obligations (NNO)	15,698	34,555	33,448	33,790	36,000	36,819	20,179	38,845	42,830	45,461
Total Depreciation and Amortization (D&A)	3,987	5,576	5,427	5,971	5,780	6,527	7,573	3,533	3,506	3,596
Debt-free, Cash-free Net Working Capital to Revenue	13.95%	2.81%	8.97%	6.65%	8.67%	15.24%	1.42%	0.73%	5.45%	5.15%
Debt-free Net Working Capital to Revenue	74.64%	4.23%	12.26%	11.08%	11.42%	21.85%	6.95%	5.83%	9.72%	9.05%
Net Working Capital to Revenue	56.24%	-1.67%	3.27%	5.35%	-6.24%	-1.25%	-12.01%	-17.17%	-8.35%	-5.33%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$2.83	$1.48	$2.15	$1.43	$1.74	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	1.25B	1.30B	1.33B	1.36B	1.37B	1.37B	979M	986M	996M	1.00B
Adjusted Diluted Earnings per Share	$0.00	$0.87	$2.83	$1.47	$2.14	$1.43	$1.74	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	1.25B	1.30B	1.33B	1.36B	1.37B	1.37B	980M	987M	997M	1.00B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	1.25B	2.09B	2.14B	1.79B	0.00	3.60B	1.29B	1.30B	1.31B	1.31B
Normalized Net Operating Profit after Tax (NOPAT)	1,911	21,381	2,906	3,632	3,499	1,525	2,620	2,835	3,458	3,973
Normalized NOPAT Margin	17.29%	34.11%	8.66%	10.09%	10.16%	9.15%	14.61%	14.86%	15.91%	17.25%
Pre Tax Income Margin	30.13%	3.15%	11.25%	6.18%	11.57%	6.55%	9.22%	12.60%	12.44%	11.58%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	22.67	3.42	2.43	3.47	1.84	2.28	2.66	2.56	2.39
NOPAT to Interest Expense	0.00	13.90	2.91	2.37	2.18	1.69	2.03	1.96	2.00	2.08
EBIT Less CapEx to Interest Expense	0.00	17.15	-1.30	-2.46	-0.99	-4.29	-3.23	-2.27	-1.71	-1.29
NOPAT Less CapEx to Interest Expense	0.00	8.37	-1.81	-2.52	-2.27	-4.44	-3.48	-2.97	-2.27	-1.61
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	66.21%	98.16%	31.95%	64.07%	46.50%	76.36%	130.24%	61.45%	61.56%	61.95%
Augmented Payout Ratio	66.21%	98.16%	31.95%	64.07%	46.50%	76.36%	130.24%	61.45%	61.56%	61.95%

This table displays calculated financial ratios and metrics derived from Exelon's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.37%	0.00%	0.00%	0.00%	23.43%	0.00%	8.63%	11.27%	2.91%	1.94%	0.00%
EBITDA Growth	-31.06%	-65.07%	0.00%	0.00%	6.89%	141.10%	-0.29%	9.42%	3.30%	0.78%	2.84%
EBIT Growth	38.85%	-100.00%	0.00%	0.00%	6.27%	0.00%	-2.14%	15.90%	4.07%	-0.60%	0.00%
NOPAT Growth	26.73%	-100.00%	0.00%	0.00%	15.17%	0.00%	10.33%	42.64%	8.99%	8.80%	0.00%
Net Income Growth	-45.00%	0.00%	0.00%	2,958.33%	3.55%	0.00%	-1.64%	30.61%	1.00%	5.03%	-16.67%
EPS Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1.49%	32.35%	0.00%	0.00%	36.36%
Operating Cash Flow Growth	24.44%	164.57%	0.00%	0.00%	-59.03%	93.55%	104.96%	14.49%	10.32%	1.06%	20.97%
Free Cash Flow Firm Growth	-185.13%	-146.59%	0.00%	-194.33%	91.88%	52.89%	0.00%	99.08%	53.10%	31.58%	94.22%
Invested Capital Growth	1,713.74%	15.67%	0.00%	0.00%	10.17%	7.86%	0.00%	2.11%	5.27%	5.54%	5.78%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	-13.39%	24.12%	-10.27%	12.62%	-11.29%	14.79%	-11.11%	-100.00%
EBITDA Q/Q Growth	0.00%	-56.38%	142.97%	-17.59%	22.40%	-1.62%	0.49%	-9.57%	15.55%	-4.02%	-56.39%
EBIT Q/Q Growth	0.00%	-100.00%	0.00%	-30.62%	42.82%	-2.91%	1.71%	-17.83%	28.25%	-7.26%	-100.00%
NOPAT Q/Q Growth	0.00%	-100.00%	0.00%	-37.00%	76.57%	-8.50%	8.41%	-18.56%	34.91%	-8.66%	-100.00%
Net Income Q/Q Growth	5,733.33%	0.00%	0.00%	-48.73%	104.08%	-12.00%	6.82%	-31.91%	57.81%	-8.49%	-101.08%
EPS Q/Q Growth	0.00%	0.00%	0.00%	-49.25%	105.88%	-11.43%	6.45%	-31.82%	55.56%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	-80.49%	-33.61%	163.84%	19.89%	-7.84%	-29.70%	47.38%	15.53%	-15.57%	-15.85%
Free Cash Flow Firm Q/Q Growth	-188.53%	86.61%	100.00%	0.00%	92.38%	22.32%	-1,598.83%	99.08%	-287.65%	-13.33%	-45.75%
Invested Capital Q/Q Growth	0.00%	3.51%	-100.00%	0.00%	-2.12%	1.33%	2.00%	0.93%	0.91%	1.59%	2.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	45.68%	0.00%	62.41%	64.16%	59.92%	-22.72%	60.12%	62.84%	61.28%	-25.01%	0.00%
EBITDA Margin	40.41%	0.00%	37.30%	35.49%	35.00%	38.37%	34.24%	34.90%	35.13%	37.93%	0.00%
Operating Margin	20.87%	0.00%	19.88%	14.61%	18.78%	20.31%	18.43%	17.03%	19.43%	20.04%	0.00%
EBIT Margin	23.38%	0.00%	21.84%	17.50%	20.13%	21.79%	19.68%	18.22%	20.36%	21.24%	0.00%
Profit (Net Income) Margin	13.95%	0.00%	12.03%	7.12%	11.71%	11.48%	10.89%	8.36%	11.49%	11.83%	0.00%
Tax Burden Percent	88.02%	0.00%	83.31%	82.45%	91.26%	86.03%	91.26%	90.69%	93.40%	93.09%	100.00%
Interest Burden Percent	67.78%	0.00%	66.09%	49.35%	63.70%	61.25%	60.64%	50.56%	60.42%	59.81%	0.00%
Effective Tax Rate	11.98%	0.00%	16.69%	17.55%	8.74%	13.97%	8.74%	9.31%	6.61%	6.91%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	5.75%	10.68%	5.03%	5.99%	6.09%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	4.96%	9.05%	4.17%	5.05%	5.25%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	8.02%	15.24%	7.21%	8.41%	8.80%	0.00%
Return on Equity (ROE)	0.00%	0.00%	0.00%	0.00%	0.00%	13.76%	25.92%	12.23%	14.40%	14.89%	0.00%
Cash Return on Invested Capital (CROIC)	-106.20%	-9.75%	0.00%	-200.00%	-9.68%	-2.31%	-189.81%	3.36%	0.48%	0.27%	0.38%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	0.00%	0.00%	4.80%	8.47%	4.08%	4.55%	4.67%	0.00%
Return on Assets (ROA)	0.00%	0.00%	0.00%	0.00%	0.00%	2.53%	4.69%	1.87%	2.57%	2.60%	0.00%
Return on Common Equity (ROCE)	0.00%	0.00%	0.00%	0.00%	0.00%	6.74%	25.92%	12.23%	14.40%	0.00%	0.00%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	8.89%	9.26%	9.12%	0.00%	8.91%
Net Operating Profit after Tax (NOPAT)	890	0.00	921	580	1,025	938	1,017	828	1,117	1,020	0.00
NOPAT Margin	18.37%	0.00%	16.56%	12.05%	17.14%	17.48%	16.82%	15.44%	18.15%	18.65%	0.00%
Net Nonoperating Expense Percent (NNEP)	1.31%	0.00%	0.00%	1.08%	0.82%	0.79%	1.63%	0.86%	0.94%	0.85%	0.02%
Return On Investment Capital (ROIC_SIMPLE)	-	0.00%	-	-	-	1.34%	-	-	-	1.39%	0.00%
Cost of Revenue to Revenue	54.32%	0.00%	37.59%	35.84%	40.08%	122.72%	39.88%	37.16%	38.72%	125.01%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	20.69%	24.84%	19.85%	0.00%	21.03%	22.55%	20.72%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	24.81%	0.00%	42.53%	49.54%	41.14%	-43.03%	41.68%	45.94%	41.84%	-45.17%	0.00%
Earnings before Interest and Taxes (EBIT)	1,133	0.00	1,215	843	1,204	1,169	1,189	977	1,253	1,162	0.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,958	854	2,075	1,710	2,093	2,059	2,069	1,871	2,162	2,075	905
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.82	2.10	0.00	2.01	1.85	0.00	1.84	1.71	1.99	0.00	2.19
Price to Tangible Book Value (P/TBV)	2.49	2.87	0.00	2.73	2.51	0.00	2.47	2.29	2.65	0.00	2.88
Price to Revenue (P/Rev)	0.00	2.73	0.00	0.00	0.00	2.06	2.16	1.97	2.31	2.14	2.62
Price to Earnings (P/E)	0.00	23.99	0.00	0.00	0.00	19.27	20.68	18.47	21.81	20.06	22.30
Dividend Yield	3.70%	3.37%	3.47%	3.60%	3.90%	4.18%	3.97%	4.32%	3.70%	4.04%	3.34%
Earnings Yield	0.00%	4.17%	0.00%	0.00%	0.00%	5.19%	4.84%	5.41%	4.58%	4.99%	4.49%
Enterprise Value to Invested Capital (EV/IC)	1.33	1.43	0.00	1.34	1.32	1.28	1.31	1.26	1.37	1.31	1.44
Enterprise Value to Revenue (EV/Rev)	0.00	4.77	0.00	0.00	0.00	4.04	4.13	3.92	4.26	4.12	4.64
Enterprise Value to EBITDA (EV/EBITDA)	20.15	12.31	0.00	0.00	25.78	11.05	11.58	11.02	11.96	11.59	13.45
Enterprise Value to EBIT (EV/EBIT)	0.00	23.61	0.00	0.00	0.00	19.79	20.84	19.65	21.27	20.69	24.73
Enterprise Value to NOPAT (EV/NOPAT)	0.00	32.08	0.00	0.00	0.00	25.30	25.76	23.44	25.04	23.80	24.73
Enterprise Value to Operating Cash Flow (EV/OCF)	27.08	18.67	0.00	14.83	22.25	18.64	17.62	16.53	17.57	17.02	18.49
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	38.02	295.41	507.56	392.73
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.56	1.62	0.00	1.72	1.70	1.71	1.74	1.77	1.73	1.73	1.75
Long-Term Debt to Equity	1.44	1.44	0.00	1.61	1.56	1.56	1.64	1.66	1.66	1.61	1.66
Financial Leverage	1.32	0.99	0.00	1.76	1.58	1.62	1.68	1.73	1.67	1.68	1.68
Leverage Ratio	3.76	3.84	0.00	3.91	3.85	3.91	3.96	3.97	3.94	3.98	3.96
Compound Leverage Factor	2.55	0.00	0.00	1.93	2.45	2.39	2.40	2.01	2.38	2.38	0.00
Debt to Total Capital	60.89%	61.81%	0.00%	63.17%	62.91%	63.08%	63.52%	63.85%	63.38%	63.41%	63.62%
Short-Term Debt to Total Capital	4.76%	6.77%	0.00%	4.03%	4.91%	5.63%	3.79%	3.82%	2.73%	4.50%	3.34%
Long-Term Debt to Total Capital	56.13%	55.04%	0.00%	59.14%	57.99%	57.45%	59.72%	60.03%	60.65%	58.91%	60.27%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	39.11%	38.19%	0.00%	36.83%	37.09%	0.00%	36.48%	36.15%	36.62%	0.00%	36.38%
Debt to EBITDA	9.45	5.42	0.00	0.00	12.45	5.54	5.72	5.71	5.65	5.70	6.08
Net Debt to EBITDA	9.10	5.26	0.00	0.00	12.17	5.40	5.54	5.49	5.47	5.56	5.84
Long-Term Debt to EBITDA	8.72	4.83	0.00	0.00	11.48	5.05	5.38	5.37	5.40	5.30	5.76
Debt to NOPAT	0.00	14.13	0.00	0.00	0.00	12.70	12.73	12.14	11.82	11.71	11.18
Net Debt to NOPAT	0.00	13.71	0.00	0.00	0.00	12.36	12.31	11.68	11.45	11.41	10.74
Long-Term Debt to NOPAT	0.00	12.59	0.00	0.00	0.00	11.56	11.97	11.41	11.31	10.88	10.59
Altman Z-Score	0.48	0.67	0.00	0.51	0.48	0.66	0.71	0.67	0.74	0.69	0.75
Noncontrolling Interest Sharing Ratio	1.64%	0.00%	0.00%	0.00%	0.00%	51.00%	0.00%	0.00%	0.00%	100.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.81	0.69	0.00	0.95	0.85	0.82	1.03	1.03	1.09	0.87	1.09
Quick Ratio	0.44	0.37	0.00	0.43	0.41	0.38	0.54	0.56	0.58	0.43	0.62
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-64,352	-8,615	0.00	-68,569	-5,224	-4,058	-68,942	-632	-2,450	-2,777	-4,047
Operating Cash Flow to CapEx	0.00%	37.04%	25.73%	70.79%	82.53%	76.56%	56.20%	86.05%	99.65%	73.66%	61.67%
Free Cash Flow to Firm to Interest Expense	-176.31	0.00	0.00	-160.58	-11.95	-8.96	-147.31	-1.31	-4.94	-5.95	-578.14
Operating Cash Flow to Interest Expense	10.24	0.00	1.17	2.99	3.50	3.11	2.12	3.03	3.41	3.05	171.43
Operating Cash Flow Less CapEx to Interest Expense	10.24	0.00	-3.39	-1.23	-0.74	-0.95	-1.65	-0.49	-0.01	-1.09	-106.57
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.17	0.00	0.00	0.00	0.22	0.43	0.22	0.22	0.22	0.22
Accounts Receivable Turnover	0.00	5.94	0.00	0.00	0.00	6.28	0.00	6.66	6.57	6.47	6.06
Inventory Turnover	0.00	16.54	0.00	0.00	0.00	16.45	0.00	17.45	16.54	16.47	16.81
Fixed Asset Turnover	0.00	0.29	0.00	0.00	0.00	0.30	0.00	0.31	0.31	0.30	0.30
Accounts Payable Turnover	0.00	3.83	0.00	0.00	0.00	4.10	0.00	0.00	5.01	4.66	4.94
Days Sales Outstanding (DSO)	0.00	61.47	0.00	0.00	0.00	58.14	0.00	54.82	55.52	56.39	60.24
Days Inventory Outstanding (DIO)	0.00	22.07	0.00	0.00	0.00	22.19	0.00	20.92	22.07	22.16	21.72
Days Payable Outstanding (DPO)	0.00	95.35	0.00	0.00	0.00	88.94	0.00	0.00	72.92	78.37	73.91
Cash Conversion Cycle (CCC)	0.00	-11.80	0.00	0.00	0.00	-8.61	0.00	75.74	4.67	0.18	8.05
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	61,435	63,589	0.00	69,149	67,684	68,585	69,959	70,609	71,251	72,382	74,006
Invested Capital Turnover	0.00	0.32	0.00	0.00	0.00	0.33	0.63	0.33	0.33	0.33	0.32
Increase / (Decrease) in Invested Capital	65,242	8,615	0.00	69,149	6,249	4,996	69,959	1,460	3,567	3,797	4,047
Enterprise Value (EV)	81,557	90,910	51,417	92,373	89,454	87,684	91,819	89,202	97,609	94,803	106,822
Market Capitalization	44,704	52,065	51,417	50,433	47,240	44,854	47,921	44,745	52,980	49,342	60,423
Book Value per Share	$19.11	$19.04	$0.00	$25.21	$19.57	$0.00	$26.06	$20.02	$20.38	$0.00	$21.05
Tangible Book Value per Share	$13.96	$13.94	$0.00	$18.54	$14.48	($5.09)	$19.43	$14.95	$15.30	($5.06)	$16.00
Total Capital	62,855	64,794	0.00	68,091	68,665	69,763	71,431	72,343	72,698	73,570	75,877
Total Debt	38,273	40,050	0.00	43,012	43,195	44,008	45,370	46,191	46,076	46,649	48,270
Total Long-Term Debt	35,283	35,662	0.00	40,271	39,821	40,082	42,661	43,429	44,091	43,337	45,732
Net Debt	36,853	38,845	0.00	41,940	42,214	42,830	43,898	44,457	44,629	45,461	46,399
Capital Expenditures (CapEx)	0.00	1,968	1,881	1,804	1,855	1,843	1,765	1,699	1,695	1,936	1,946
Debt-free, Cash-free Net Working Capital (DFCFNWC)	138	140	0.00	1,513	1,358	1,185	1,737	1,580	1,456	1,187	1,652
Debt-free Net Working Capital (DFNWC)	1,328	1,113	0.00	2,347	2,093	2,112	2,946	3,044	2,624	2,085	3,234
Net Working Capital (NWC)	-1,662	-3,275	0.00	-394	-1,281	-1,814	237	282	639	-1,227	696
Net Nonoperating Expense (NNE)	214	0.00	252	237	325	322	359	380	410	373	7.00
Net Nonoperating Obligations (NNO)	36,853	38,845	0.00	44,070	42,214	42,830	43,898	44,457	44,629	45,461	46,399
Total Depreciation and Amortization (D&A)	825	854	860	867	889	890	880	894	909	913	905
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.73%	0.00%	0.00%	0.00%	5.45%	7.82%	6.95%	6.35%	5.15%	7.17%
Debt-free Net Working Capital to Revenue	0.00%	5.83%	0.00%	0.00%	0.00%	9.72%	13.27%	13.38%	11.45%	9.05%	14.04%
Net Working Capital to Revenue	0.00%	-17.17%	0.00%	0.00%	0.00%	-8.35%	1.07%	1.24%	2.79%	-5.33%	3.02%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.62	$0.66	$0.45	$0.70	$0.00	$0.90
Adjusted Weighted Average Basic Shares Outstanding	988M	986M	995M	995M	996M	996M	1B	1.00B	1.00B	1.00B	1.01B
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.62	$0.66	$0.45	$0.70	$0.00	$0.90
Adjusted Weighted Average Diluted Shares Outstanding	989M	987M	996M	996M	997M	997M	1.00B	1.00B	1.00B	1.00B	1.01B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.62	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	1.30B	1.30B	1.30B	1.30B	1.30B	1.31B	1.31B	1.31B	1.31B	1.31B	1.32B
Normalized Net Operating Profit after Tax (NOPAT)	890	0.00	921	580	1,025	938	1,015	828	1,114	1,020	0.00
Normalized NOPAT Margin	18.37%	0.00%	16.56%	12.05%	17.14%	17.48%	16.79%	15.44%	18.11%	18.65%	0.00%
Pre Tax Income Margin	15.85%	0.00%	14.43%	8.63%	12.83%	13.34%	11.93%	9.21%	12.30%	12.71%	0.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.10	0.00	2.95	1.97	2.76	2.58	2.54	2.02	2.53	2.49	0.00
NOPAT to Interest Expense	2.44	0.00	2.24	1.36	2.35	2.07	2.17	1.71	2.25	2.18	0.00
EBIT Less CapEx to Interest Expense	3.10	0.00	-1.62	-2.25	-1.49	-1.49	-1.23	-1.49	-0.89	-1.66	-278.00
NOPAT Less CapEx to Interest Expense	2.44	0.00	-2.33	-2.87	-1.90	-2.00	-1.60	-1.80	-1.17	-1.96	-278.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	61.45%	0.00%	0.00%	0.00%	61.56%	62.84%	60.98%	61.80%	61.95%	62.87%
Augmented Payout Ratio	0.00%	61.45%	0.00%	0.00%	0.00%	61.56%	62.84%	60.98%	61.80%	61.95%	62.87%

Key Financial Trends

Exelon Corp (NASDAQ: EXC) has shown several noteworthy financial trends and key highlights over the past four years through the Q1 2025 period. Here is a summary of critical observations based on the income statements, balance sheets, and cash flow statements:

Strong Net Income Growth in Recent Quarters: Exelon reported a consolidated net income of $908 million in Q1 2025, a significant increase compared to $647 million in Q4 2024 and strong quarterly figures in 2024, demonstrating robust profitability.
Increasing Earnings Per Share: Diluted earnings per share increased to $0.90 in Q1 2025 from $0.64-$0.70 range in most quarters of 2024 and 2023, reflecting improved operational efficiency and profitability.
Positive Operating Cash Flow: Quarterly net cash from operating activities was $1.2 billion in Q1 2025, consistent with strong operating cash flow generation in previous quarters, supporting company liquidity and capital expenditures.
Capital Expenditures Invested in Growth: Purchase of property, plant, and equipment remained high, at about $1.95 billion in Q1 2025, consistent with large investments each quarter to maintain and grow physical assets.
Equity Financing and Debt Issuance Supporting Investments: In Q1 2025, Exelon issued about $2.42 billion in debt and $173 million in common equity, reflecting strategic financing to fund growth and manage capital structure.
Dividend Consistency and Increases: Exelon raised its quarterly dividend per share from about $0.34-$0.38 in 2022-2024 to $0.40 in Q1 2025, indicating confidence in sustained cash flows and return of capital to shareholders.
Stable and Growing Asset Base: Total assets increased from around $95 billion at end of 2022 to about $109 billion by Q1 2025, reflecting ongoing capital expansion and acquisition of long-lived assets.
Consistent Long-Term Debt Level: Long-term debt has gradually grown from $35.7 billion at end of 2022 to $45.7 billion by Q1 2025, showing managed leverage aligned with company growth strategies.
Volatile Total Revenues and Costs: Total revenues and cost of revenues fluctuated quarterly, with a recent anomaly in Q1 2025 showing zero total revenue and cost figures due to data reporting issues, complicating trend analysis in that metric.
High Interest Expense Impacting Net Income: Interest expense increased notably to $7 million in Q1 2025 from typical quarterly figures around $400-500 million, though the net income attributable to common shareholders remains positive; this may indicate a reporting inconsistency or a non-recurring cost impacting the quarter.

Summary: Over the last four years, Exelon demonstrates a solid earnings profile with consistently positive net income and growing earnings per share. The company maintains large capital investments to support growth and asset base expansion while managing its long-term debt carefully. The dividend payments have been stable or increasing, reflecting confidence in cash generation. Operating cash flows remain strong, supporting both investment and shareholder returns. Investors should note some irregularities in the reported Q1 2025 revenue and interest figures, which may be reporting artifacts rather than operational issues. Overall, Exelon appears financially healthy with solid fundamentals for retail investors considering the stock.

08/03/25 07:30 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Exelon's Financials

When does Exelon's financial year end?

According to the most recent income statement we have on file, Exelon's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Exelon's net income changed over the last 9 years?

In the past 9 years, Exelon's net income has ranged from $1.20 billion in 2016 to $3.87 billion in 2017, and is currently $2.46 billion as of their latest financial filing in 2024. See where experts think Exelon is headed by visiting Exelon's forecast page.

What is Exelon's operating income?

Exelon's total operating income in 2024 was $4.32 billion, based on the following breakdown:

Total Gross Profit: $9.41 billion
Total Operating Expenses: $5.09 billion

How has Exelon's revenue changed over the last 9 years?

Over the last 9 years, Exelon's total revenue changed from $11.05 billion in 2015 to $23.03 billion in 2024, a change of 108.4%.

How much debt does Exelon have?

Exelon's total liabilities were at $80.86 billion at the end of 2024, a 6.3% increase from 2023, and a 18.8% increase since 2015.

How much cash does Exelon have?

In the past 9 years, Exelon's cash and equivalents has ranged from $357 million in 2024 to $6.50 billion in 2015, and is currently $357 million as of their latest financial filing in 2024.

How has Exelon's book value per share changed over the last 9 years?

Over the last 9 years, Exelon's book value per share changed from 21.19 in 2015 to 0.00 in 2024, a change of -100.0%.

Related Companies

This page (NASDAQ:EXC) was last updated on 8/3/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exelon (EXC) Financials

Key Financial Trends

Frequently Asked Questions About Exelon's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Exelon (EXC) Financials

Annual Income Statements for Exelon

Quarterly Income Statements for Exelon

Annual Cash Flow Statements for Exelon

Quarterly Cash Flow Statements for Exelon

Annual Balance Sheets for Exelon

Quarterly Balance Sheets for Exelon

Annual Metrics And Ratios for Exelon

Quarterly Metrics And Ratios for Exelon

Key Financial Trends

Frequently Asked Questions About Exelon's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools